AngioDynamics (ANGO) earnings preview: reversing revenue decline?

5:23 pm ET, 08 Jul 2018

AngioDynamics, Inc. (ANGO) is expected to report earnings on July 11 before market open.  The report will be for the fiscal quarter ending May 2018.  The shares are trading at 22.24, down -0.54%.

What are ANGO earnings expectations?  What news will the market be watching out for?  

AngioDynamics is a medical device supplier whose stock has been on the run since early May.  The company has been battling declining revenue and profit margin.  However, the medical device maker is shifting focus to research and development.

In 2018, the company's focus has been on commercial discipline, global reach (currently AngioDynamics sell predominantly in the US), and new technologies that serve patent needs.  

AngioDynamics, Inc. has a mixed history of beating analysts’ earnings estimates.  In the past four quarters, the company: 

  • Beat analyst EPS estimates by 3 cents ($.19 actuals vs. $.16 forecast) in FQ4’17;
  • Missed analyst EPS estimates by 4 cents ($.12 actuals vs. $.16 forecast) in FQ1’18;
  • Missed analyst EPS estimates by 1 cents ($.16 actuals vs. $.17 forecast) in FQ2’18;
  • Beat analyst EPS estimates by 5 cents ($.25 actuals vs. $.20 forecast) in FQ3’18.

For FQ4’18, EPS is expected to grow by 11% year-over-year to $.21, while revenue is expected to grow 2% year-over-year to $89 million.  


Over the last month, AngioDynamics, Inc. (ANGO) returned +7.08%.

AngioDynamics, Inc. (ANGO) forward P/E ratio is 23.92, and it’s low compared to its industry peers’ P/E ratio.

AngioDynamics, Inc. (ANGO) short share of float is 5.53%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

AngioDynamics, Inc. (ANGO) average analyst price target ($18.00) is -19.06% below its current price ($22.24).

For the latest price and information on AngioDynamics, Inc., please visit Finstead and search for "ANGO price" or "ANGO news".

AngioDynamics manufactures medical, surgical, and diagnostic devices. It sells products in three categories: peripheral vascular, vascular access, and oncology/surgery. The peripheral vascular products contribute the largest proportion of revenue and include fluid management, venous, drainage, angiographic, and thrombus management products. 

AngioDynamics generates the majority of its revenue in the United States.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

AngioDynamics, Inc. (ANGO) Stock Guide

Updated at: 1:36 am ET, 12 Jul 2020

Before we start: if you're looking for ANGO stock price, you can quickly find it out by visiting Finny and typing "ANGO quote". If you're looking for a quick scoop on ANGO stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "ANGO". You'll get all this info in one place. Or you can just type "ANGO news" to get the latest stock news.

Looking to buy or sell AngioDynamics, Inc. (ANGO)? Interested in getting the full scoop on ANGO, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this ANGO stock guide, we'll address key questions about ANGO, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are ANGO earnings?
2. When is ANGO earnings date?
3. What is ANGO stock forecast (i.e., prediction)?
4. ANGO buy or sell? What is ANGO Finny Score?
5. What are the reasons to buy ANGO? Why should I buy ANGO stock?
6. What are the reasons to sell ANGO? Why should I sell ANGO stock?
7. What are ANGO key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are ANGO earnings?

ANGO trailing 12-month earnings per share (EPS) is $1.29.

2. When is ANGO earnings date?

ANGO earnings date is July 16, 2020.

Analyst Predictions

3. What is ANGO stock forecast (i.e., prediction)?

Based on ANGO analyst price targets, ANGO stock forecast is $14.00 (for a year from now). That means the average analyst price target for ANGO stock is $14.00. The prediction is based on 5 analyst estimates.

The low price target for ANGO is $14.00, while the high price target is $14.00.

ANGO analyst rating is Hold.

Analysis

4. ANGO buy or sell? What is ANGO Finny Score?

#{finnyScore:80}Our quantitative analysis shows 8 reasons to buy and 2 reasons to sell ANGO, resulting in Finny Score of 80.

5. What are the reasons to buy ANGO? Why should I buy ANGO stock?

Here are the reasons to buy ANGO stock:

  • ANGO quarterly revenue growth was 6.50%, higher than the industry and sector average revenue growth (2.59% and 1.16%, respectively). See ANGO revenue growth chart.
  • ANGO profitability is improving. The YoY profit margin change was 17.92 percentage points. See ANGO profitability chart.
  • ANGO Price/Book ratio is 0.62, which is low compared to its industry peers’ P/B ratios. See ANGO forward Price/Book ratio chart.
  • ANGO Price/Sales ratio is 1.36, which is low compared to its industry peers’ P/S ratios. See ANGO forward Price/Sales ratio chart.
  • ANGO PEG ratio (P/E adjusted for growth) is 7.73, which is low compared to its industry peers’ PEG ratios. See ANGO PEG chart.
  • ANGO average analyst price target ($14.00) is above its current price ($10.10). See ANGO price target chart.
  • ANGO cash to debt ratio is 1.13, higher than the average industry (0.19) and sector (0.16) cash to debt ratio. See ANGO cash to debt chart.
  • ANGO Enterprise Value/Revenue multiple is 1.45, which is low compared to its industry peers’ Enterprise Value/Revenue multiples. See ANGO Enterprise Value/Revenue chart.

6. What are the reasons to sell ANGO? Why should I sell ANGO stock?

Let's look at the reasons to sell ANGO stock (i.e., the bear case):

  • ANGO forward P/E ratio is 91.00, which is high compared to its industry peers’ P/E ratios. See ANGO forward P/E ratio chart.
  • ANGO short interest (days to cover the shorts) ratio is 3.12. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ANGO short interest ratio chart.

Key Stats

7. What are ANGO key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for ANGO:

Metrics ANGO
Price $8.99
Average Price Target / Upside $14.00 / 55.64%
Average Analyst Rating Hold
Forward Dividend Yield 0.00%
Industry Medical Instruments & Supplies
Sector Healthcare
Number of Employees 1,145
Market Cap $355.46M
Forward P/E Ratio 78.58
Price/Book Ratio 1.35
Revenue (TTM) $264.16M
YoY Quarterly Revenue Growth -39.40%
Profit Margin -62.76%

If you liked this analysis, check out Stock Guides for other stocks.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Use Finny to ask any finance or investment question. Big or small. Personal or general.
Follow Us